Global Cell-Free DNA (cfDNA) Testing Market Research Report 2024(Status and Outlook)
Report Overview
Cell-Free DNA are fragments of DNA which circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noninvasive screening test used to help detect graft rejection, identify mutations in cancer patients and detect various chromosomal abnormalities in the fetus, to know the gender of the fetus. The discovery of cfDNA has opened up to new potentials in the field of oncology, gynecology, transplantation and infectious diseases.
This report provides a deep insight into the global Cell-Free DNA (cfDNA) Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell-Free DNA (cfDNA) Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell-Free DNA (cfDNA) Testing market in any manner.
Global Cell-Free DNA (cfDNA) Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche Holdings
Sequenom
Trovagene
Market Segmentation (by Type)
Donor-Derived Cell-Free DNA (DdcfDNA)
Circulating Cell-Free Tumor DNA (CtDNA)
Cell-Free Fetal DNA (NIPT)
Market Segmentation (by Application)
Hospital
Ambulatory Surgical Centers
Cancer Research Institutes
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell-Free DNA (cfDNA) Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Cell-Free DNA are fragments of DNA which circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noninvasive screening test used to help detect graft rejection, identify mutations in cancer patients and detect various chromosomal abnormalities in the fetus, to know the gender of the fetus. The discovery of cfDNA has opened up to new potentials in the field of oncology, gynecology, transplantation and infectious diseases.
This report provides a deep insight into the global Cell-Free DNA (cfDNA) Testing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Cell-Free DNA (cfDNA) Testing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Cell-Free DNA (cfDNA) Testing market in any manner.
Global Cell-Free DNA (cfDNA) Testing Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Agilent Technology
Allenex
Biocept
Biodesix
CareDx
Guardant Health
Illumania
Invited
Natera
Quest Diagnostics
Roche Holdings
Sequenom
Trovagene
Market Segmentation (by Type)
Donor-Derived Cell-Free DNA (DdcfDNA)
Circulating Cell-Free Tumor DNA (CtDNA)
Cell-Free Fetal DNA (NIPT)
Market Segmentation (by Application)
Hospital
Ambulatory Surgical Centers
Cancer Research Institutes
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cell-Free DNA (cfDNA) Testing Market
- Overview of the regional outlook of the Cell-Free DNA (cfDNA) Testing Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cell-Free DNA (cfDNA) Testing Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cell-Free DNA (cfDNA) Testing
1.2 Key Market Segments
1.2.1 Cell-Free DNA (cfDNA) Testing Segment by Type
1.2.2 Cell-Free DNA (cfDNA) Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL-FREE DNA (CFDNA) TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell-Free DNA (cfDNA) Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cell-Free DNA (cfDNA) Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL-FREE DNA (CFDNA) TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Cell-Free DNA (cfDNA) Testing Sales by Manufacturers (2019-2024)
3.2 Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell-Free DNA (cfDNA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell-Free DNA (cfDNA) Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell-Free DNA (cfDNA) Testing Sales Sites, Area Served, Product Type
3.6 Cell-Free DNA (cfDNA) Testing Market Competitive Situation and Trends
3.6.1 Cell-Free DNA (cfDNA) Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell-Free DNA (cfDNA) Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELL-FREE DNA (CFDNA) TESTING INDUSTRY CHAIN ANALYSIS
4.1 Cell-Free DNA (cfDNA) Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL-FREE DNA (CFDNA) TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELL-FREE DNA (CFDNA) TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Type (2019-2024)
6.3 Global Cell-Free DNA (cfDNA) Testing Market Size Market Share by Type (2019-2024)
6.4 Global Cell-Free DNA (cfDNA) Testing Price by Type (2019-2024)
7 CELL-FREE DNA (CFDNA) TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell-Free DNA (cfDNA) Testing Market Sales by Application (2019-2024)
7.3 Global Cell-Free DNA (cfDNA) Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Cell-Free DNA (cfDNA) Testing Sales Growth Rate by Application (2019-2024)
8 CELL-FREE DNA (CFDNA) TESTING MARKET SEGMENTATION BY REGION
8.1 Global Cell-Free DNA (cfDNA) Testing Sales by Region
8.1.1 Global Cell-Free DNA (cfDNA) Testing Sales by Region
8.1.2 Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Cell-Free DNA (cfDNA) Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell-Free DNA (cfDNA) Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell-Free DNA (cfDNA) Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell-Free DNA (cfDNA) Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell-Free DNA (cfDNA) Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agilent Technology
9.1.1 Agilent Technology Cell-Free DNA (cfDNA) Testing Basic Information
9.1.2 Agilent Technology Cell-Free DNA (cfDNA) Testing Product Overview
9.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Product Market Performance
9.1.4 Agilent Technology Business Overview
9.1.5 Agilent Technology Cell-Free DNA (cfDNA) Testing SWOT Analysis
9.1.6 Agilent Technology Recent Developments
9.2 Allenex
9.2.1 Allenex Cell-Free DNA (cfDNA) Testing Basic Information
9.2.2 Allenex Cell-Free DNA (cfDNA) Testing Product Overview
9.2.3 Allenex Cell-Free DNA (cfDNA) Testing Product Market Performance
9.2.4 Allenex Business Overview
9.2.5 Allenex Cell-Free DNA (cfDNA) Testing SWOT Analysis
9.2.6 Allenex Recent Developments
9.3 Biocept
9.3.1 Biocept Cell-Free DNA (cfDNA) Testing Basic Information
9.3.2 Biocept Cell-Free DNA (cfDNA) Testing Product Overview
9.3.3 Biocept Cell-Free DNA (cfDNA) Testing Product Market Performance
9.3.4 Biocept Cell-Free DNA (cfDNA) Testing SWOT Analysis
9.3.5 Biocept Business Overview
9.3.6 Biocept Recent Developments
9.4 Biodesix
9.4.1 Biodesix Cell-Free DNA (cfDNA) Testing Basic Information
9.4.2 Biodesix Cell-Free DNA (cfDNA) Testing Product Overview
9.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Product Market Performance
9.4.4 Biodesix Business Overview
9.4.5 Biodesix Recent Developments
9.5 CareDx
9.5.1 CareDx Cell-Free DNA (cfDNA) Testing Basic Information
9.5.2 CareDx Cell-Free DNA (cfDNA) Testing Product Overview
9.5.3 CareDx Cell-Free DNA (cfDNA) Testing Product Market Performance
9.5.4 CareDx Business Overview
9.5.5 CareDx Recent Developments
9.6 Guardant Health
9.6.1 Guardant Health Cell-Free DNA (cfDNA) Testing Basic Information
9.6.2 Guardant Health Cell-Free DNA (cfDNA) Testing Product Overview
9.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Product Market Performance
9.6.4 Guardant Health Business Overview
9.6.5 Guardant Health Recent Developments
9.7 Illumania
9.7.1 Illumania Cell-Free DNA (cfDNA) Testing Basic Information
9.7.2 Illumania Cell-Free DNA (cfDNA) Testing Product Overview
9.7.3 Illumania Cell-Free DNA (cfDNA) Testing Product Market Performance
9.7.4 Illumania Business Overview
9.7.5 Illumania Recent Developments
9.8 Invited
9.8.1 Invited Cell-Free DNA (cfDNA) Testing Basic Information
9.8.2 Invited Cell-Free DNA (cfDNA) Testing Product Overview
9.8.3 Invited Cell-Free DNA (cfDNA) Testing Product Market Performance
9.8.4 Invited Business Overview
9.8.5 Invited Recent Developments
9.9 Natera
9.9.1 Natera Cell-Free DNA (cfDNA) Testing Basic Information
9.9.2 Natera Cell-Free DNA (cfDNA) Testing Product Overview
9.9.3 Natera Cell-Free DNA (cfDNA) Testing Product Market Performance
9.9.4 Natera Business Overview
9.9.5 Natera Recent Developments
9.10 Quest Diagnostics
9.10.1 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Basic Information
9.10.2 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product Overview
9.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product Market Performance
9.10.4 Quest Diagnostics Business Overview
9.10.5 Quest Diagnostics Recent Developments
9.11 Roche Holdings
9.11.1 Roche Holdings Cell-Free DNA (cfDNA) Testing Basic Information
9.11.2 Roche Holdings Cell-Free DNA (cfDNA) Testing Product Overview
9.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Product Market Performance
9.11.4 Roche Holdings Business Overview
9.11.5 Roche Holdings Recent Developments
9.12 Sequenom
9.12.1 Sequenom Cell-Free DNA (cfDNA) Testing Basic Information
9.12.2 Sequenom Cell-Free DNA (cfDNA) Testing Product Overview
9.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Product Market Performance
9.12.4 Sequenom Business Overview
9.12.5 Sequenom Recent Developments
9.13 Trovagene
9.13.1 Trovagene Cell-Free DNA (cfDNA) Testing Basic Information
9.13.2 Trovagene Cell-Free DNA (cfDNA) Testing Product Overview
9.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Product Market Performance
9.13.4 Trovagene Business Overview
9.13.5 Trovagene Recent Developments
10 CELL-FREE DNA (CFDNA) TESTING MARKET FORECAST BY REGION
10.1 Global Cell-Free DNA (cfDNA) Testing Market Size Forecast
10.2 Global Cell-Free DNA (cfDNA) Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell-Free DNA (cfDNA) Testing Market Size Forecast by Country
10.2.3 Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size Forecast by Region
10.2.4 South America Cell-Free DNA (cfDNA) Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell-Free DNA (cfDNA) Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Cell-Free DNA (cfDNA) Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cell-Free DNA (cfDNA) Testing by Type (2025-2030)
11.1.2 Global Cell-Free DNA (cfDNA) Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cell-Free DNA (cfDNA) Testing by Type (2025-2030)
11.2 Global Cell-Free DNA (cfDNA) Testing Market Forecast by Application (2025-2030)
11.2.1 Global Cell-Free DNA (cfDNA) Testing Sales (K Units) Forecast by Application
11.2.2 Global Cell-Free DNA (cfDNA) Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cell-Free DNA (cfDNA) Testing
1.2 Key Market Segments
1.2.1 Cell-Free DNA (cfDNA) Testing Segment by Type
1.2.2 Cell-Free DNA (cfDNA) Testing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CELL-FREE DNA (CFDNA) TESTING MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Cell-Free DNA (cfDNA) Testing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Cell-Free DNA (cfDNA) Testing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CELL-FREE DNA (CFDNA) TESTING MARKET COMPETITIVE LANDSCAPE
3.1 Global Cell-Free DNA (cfDNA) Testing Sales by Manufacturers (2019-2024)
3.2 Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Manufacturers (2019-2024)
3.3 Cell-Free DNA (cfDNA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Cell-Free DNA (cfDNA) Testing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Cell-Free DNA (cfDNA) Testing Sales Sites, Area Served, Product Type
3.6 Cell-Free DNA (cfDNA) Testing Market Competitive Situation and Trends
3.6.1 Cell-Free DNA (cfDNA) Testing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cell-Free DNA (cfDNA) Testing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CELL-FREE DNA (CFDNA) TESTING INDUSTRY CHAIN ANALYSIS
4.1 Cell-Free DNA (cfDNA) Testing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CELL-FREE DNA (CFDNA) TESTING MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CELL-FREE DNA (CFDNA) TESTING MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Type (2019-2024)
6.3 Global Cell-Free DNA (cfDNA) Testing Market Size Market Share by Type (2019-2024)
6.4 Global Cell-Free DNA (cfDNA) Testing Price by Type (2019-2024)
7 CELL-FREE DNA (CFDNA) TESTING MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cell-Free DNA (cfDNA) Testing Market Sales by Application (2019-2024)
7.3 Global Cell-Free DNA (cfDNA) Testing Market Size (M USD) by Application (2019-2024)
7.4 Global Cell-Free DNA (cfDNA) Testing Sales Growth Rate by Application (2019-2024)
8 CELL-FREE DNA (CFDNA) TESTING MARKET SEGMENTATION BY REGION
8.1 Global Cell-Free DNA (cfDNA) Testing Sales by Region
8.1.1 Global Cell-Free DNA (cfDNA) Testing Sales by Region
8.1.2 Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Region
8.2 North America
8.2.1 North America Cell-Free DNA (cfDNA) Testing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cell-Free DNA (cfDNA) Testing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Cell-Free DNA (cfDNA) Testing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cell-Free DNA (cfDNA) Testing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cell-Free DNA (cfDNA) Testing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Agilent Technology
9.1.1 Agilent Technology Cell-Free DNA (cfDNA) Testing Basic Information
9.1.2 Agilent Technology Cell-Free DNA (cfDNA) Testing Product Overview
9.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Product Market Performance
9.1.4 Agilent Technology Business Overview
9.1.5 Agilent Technology Cell-Free DNA (cfDNA) Testing SWOT Analysis
9.1.6 Agilent Technology Recent Developments
9.2 Allenex
9.2.1 Allenex Cell-Free DNA (cfDNA) Testing Basic Information
9.2.2 Allenex Cell-Free DNA (cfDNA) Testing Product Overview
9.2.3 Allenex Cell-Free DNA (cfDNA) Testing Product Market Performance
9.2.4 Allenex Business Overview
9.2.5 Allenex Cell-Free DNA (cfDNA) Testing SWOT Analysis
9.2.6 Allenex Recent Developments
9.3 Biocept
9.3.1 Biocept Cell-Free DNA (cfDNA) Testing Basic Information
9.3.2 Biocept Cell-Free DNA (cfDNA) Testing Product Overview
9.3.3 Biocept Cell-Free DNA (cfDNA) Testing Product Market Performance
9.3.4 Biocept Cell-Free DNA (cfDNA) Testing SWOT Analysis
9.3.5 Biocept Business Overview
9.3.6 Biocept Recent Developments
9.4 Biodesix
9.4.1 Biodesix Cell-Free DNA (cfDNA) Testing Basic Information
9.4.2 Biodesix Cell-Free DNA (cfDNA) Testing Product Overview
9.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Product Market Performance
9.4.4 Biodesix Business Overview
9.4.5 Biodesix Recent Developments
9.5 CareDx
9.5.1 CareDx Cell-Free DNA (cfDNA) Testing Basic Information
9.5.2 CareDx Cell-Free DNA (cfDNA) Testing Product Overview
9.5.3 CareDx Cell-Free DNA (cfDNA) Testing Product Market Performance
9.5.4 CareDx Business Overview
9.5.5 CareDx Recent Developments
9.6 Guardant Health
9.6.1 Guardant Health Cell-Free DNA (cfDNA) Testing Basic Information
9.6.2 Guardant Health Cell-Free DNA (cfDNA) Testing Product Overview
9.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Product Market Performance
9.6.4 Guardant Health Business Overview
9.6.5 Guardant Health Recent Developments
9.7 Illumania
9.7.1 Illumania Cell-Free DNA (cfDNA) Testing Basic Information
9.7.2 Illumania Cell-Free DNA (cfDNA) Testing Product Overview
9.7.3 Illumania Cell-Free DNA (cfDNA) Testing Product Market Performance
9.7.4 Illumania Business Overview
9.7.5 Illumania Recent Developments
9.8 Invited
9.8.1 Invited Cell-Free DNA (cfDNA) Testing Basic Information
9.8.2 Invited Cell-Free DNA (cfDNA) Testing Product Overview
9.8.3 Invited Cell-Free DNA (cfDNA) Testing Product Market Performance
9.8.4 Invited Business Overview
9.8.5 Invited Recent Developments
9.9 Natera
9.9.1 Natera Cell-Free DNA (cfDNA) Testing Basic Information
9.9.2 Natera Cell-Free DNA (cfDNA) Testing Product Overview
9.9.3 Natera Cell-Free DNA (cfDNA) Testing Product Market Performance
9.9.4 Natera Business Overview
9.9.5 Natera Recent Developments
9.10 Quest Diagnostics
9.10.1 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Basic Information
9.10.2 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product Overview
9.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product Market Performance
9.10.4 Quest Diagnostics Business Overview
9.10.5 Quest Diagnostics Recent Developments
9.11 Roche Holdings
9.11.1 Roche Holdings Cell-Free DNA (cfDNA) Testing Basic Information
9.11.2 Roche Holdings Cell-Free DNA (cfDNA) Testing Product Overview
9.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Product Market Performance
9.11.4 Roche Holdings Business Overview
9.11.5 Roche Holdings Recent Developments
9.12 Sequenom
9.12.1 Sequenom Cell-Free DNA (cfDNA) Testing Basic Information
9.12.2 Sequenom Cell-Free DNA (cfDNA) Testing Product Overview
9.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Product Market Performance
9.12.4 Sequenom Business Overview
9.12.5 Sequenom Recent Developments
9.13 Trovagene
9.13.1 Trovagene Cell-Free DNA (cfDNA) Testing Basic Information
9.13.2 Trovagene Cell-Free DNA (cfDNA) Testing Product Overview
9.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Product Market Performance
9.13.4 Trovagene Business Overview
9.13.5 Trovagene Recent Developments
10 CELL-FREE DNA (CFDNA) TESTING MARKET FORECAST BY REGION
10.1 Global Cell-Free DNA (cfDNA) Testing Market Size Forecast
10.2 Global Cell-Free DNA (cfDNA) Testing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cell-Free DNA (cfDNA) Testing Market Size Forecast by Country
10.2.3 Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size Forecast by Region
10.2.4 South America Cell-Free DNA (cfDNA) Testing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Cell-Free DNA (cfDNA) Testing by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Cell-Free DNA (cfDNA) Testing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Cell-Free DNA (cfDNA) Testing by Type (2025-2030)
11.1.2 Global Cell-Free DNA (cfDNA) Testing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Cell-Free DNA (cfDNA) Testing by Type (2025-2030)
11.2 Global Cell-Free DNA (cfDNA) Testing Market Forecast by Application (2025-2030)
11.2.1 Global Cell-Free DNA (cfDNA) Testing Sales (K Units) Forecast by Application
11.2.2 Global Cell-Free DNA (cfDNA) Testing Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell-Free DNA (cfDNA) Testing Market Size Comparison by Region (M USD)
Table 5. Global Cell-Free DNA (cfDNA) Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cell-Free DNA (cfDNA) Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cell-Free DNA (cfDNA) Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2022)
Table 10. Global Market Cell-Free DNA (cfDNA) Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cell-Free DNA (cfDNA) Testing Sales Sites and Area Served
Table 12. Manufacturers Cell-Free DNA (cfDNA) Testing Product Type
Table 13. Global Cell-Free DNA (cfDNA) Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cell-Free DNA (cfDNA) Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell-Free DNA (cfDNA) Testing Market Challenges
Table 22. Global Cell-Free DNA (cfDNA) Testing Sales by Type (K Units)
Table 23. Global Cell-Free DNA (cfDNA) Testing Market Size by Type (M USD)
Table 24. Global Cell-Free DNA (cfDNA) Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Type (2019-2024)
Table 26. Global Cell-Free DNA (cfDNA) Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Cell-Free DNA (cfDNA) Testing Market Size Share by Type (2019-2024)
Table 28. Global Cell-Free DNA (cfDNA) Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cell-Free DNA (cfDNA) Testing Sales (K Units) by Application
Table 30. Global Cell-Free DNA (cfDNA) Testing Market Size by Application
Table 31. Global Cell-Free DNA (cfDNA) Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Application (2019-2024)
Table 33. Global Cell-Free DNA (cfDNA) Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Cell-Free DNA (cfDNA) Testing Market Share by Application (2019-2024)
Table 35. Global Cell-Free DNA (cfDNA) Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Cell-Free DNA (cfDNA) Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Region (2019-2024)
Table 38. North America Cell-Free DNA (cfDNA) Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cell-Free DNA (cfDNA) Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cell-Free DNA (cfDNA) Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Cell-Free DNA (cfDNA) Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cell-Free DNA (cfDNA) Testing Sales by Region (2019-2024) & (K Units)
Table 43. Agilent Technology Cell-Free DNA (cfDNA) Testing Basic Information
Table 44. Agilent Technology Cell-Free DNA (cfDNA) Testing Product Overview
Table 45. Agilent Technology Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agilent Technology Business Overview
Table 47. Agilent Technology Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 48. Agilent Technology Recent Developments
Table 49. Allenex Cell-Free DNA (cfDNA) Testing Basic Information
Table 50. Allenex Cell-Free DNA (cfDNA) Testing Product Overview
Table 51. Allenex Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Allenex Business Overview
Table 53. Allenex Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 54. Allenex Recent Developments
Table 55. Biocept Cell-Free DNA (cfDNA) Testing Basic Information
Table 56. Biocept Cell-Free DNA (cfDNA) Testing Product Overview
Table 57. Biocept Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Biocept Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 59. Biocept Business Overview
Table 60. Biocept Recent Developments
Table 61. Biodesix Cell-Free DNA (cfDNA) Testing Basic Information
Table 62. Biodesix Cell-Free DNA (cfDNA) Testing Product Overview
Table 63. Biodesix Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Biodesix Business Overview
Table 65. Biodesix Recent Developments
Table 66. CareDx Cell-Free DNA (cfDNA) Testing Basic Information
Table 67. CareDx Cell-Free DNA (cfDNA) Testing Product Overview
Table 68. CareDx Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. CareDx Business Overview
Table 70. CareDx Recent Developments
Table 71. Guardant Health Cell-Free DNA (cfDNA) Testing Basic Information
Table 72. Guardant Health Cell-Free DNA (cfDNA) Testing Product Overview
Table 73. Guardant Health Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Guardant Health Business Overview
Table 75. Guardant Health Recent Developments
Table 76. Illumania Cell-Free DNA (cfDNA) Testing Basic Information
Table 77. Illumania Cell-Free DNA (cfDNA) Testing Product Overview
Table 78. Illumania Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Illumania Business Overview
Table 80. Illumania Recent Developments
Table 81. Invited Cell-Free DNA (cfDNA) Testing Basic Information
Table 82. Invited Cell-Free DNA (cfDNA) Testing Product Overview
Table 83. Invited Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Invited Business Overview
Table 85. Invited Recent Developments
Table 86. Natera Cell-Free DNA (cfDNA) Testing Basic Information
Table 87. Natera Cell-Free DNA (cfDNA) Testing Product Overview
Table 88. Natera Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Natera Business Overview
Table 90. Natera Recent Developments
Table 91. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Basic Information
Table 92. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product Overview
Table 93. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Quest Diagnostics Business Overview
Table 95. Quest Diagnostics Recent Developments
Table 96. Roche Holdings Cell-Free DNA (cfDNA) Testing Basic Information
Table 97. Roche Holdings Cell-Free DNA (cfDNA) Testing Product Overview
Table 98. Roche Holdings Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Roche Holdings Business Overview
Table 100. Roche Holdings Recent Developments
Table 101. Sequenom Cell-Free DNA (cfDNA) Testing Basic Information
Table 102. Sequenom Cell-Free DNA (cfDNA) Testing Product Overview
Table 103. Sequenom Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Sequenom Business Overview
Table 105. Sequenom Recent Developments
Table 106. Trovagene Cell-Free DNA (cfDNA) Testing Basic Information
Table 107. Trovagene Cell-Free DNA (cfDNA) Testing Product Overview
Table 108. Trovagene Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Trovagene Business Overview
Table 110. Trovagene Recent Developments
Table 111. Global Cell-Free DNA (cfDNA) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Cell-Free DNA (cfDNA) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Cell-Free DNA (cfDNA) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Cell-Free DNA (cfDNA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Cell-Free DNA (cfDNA) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Cell-Free DNA (cfDNA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Cell-Free DNA (cfDNA) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Cell-Free DNA (cfDNA) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Cell-Free DNA (cfDNA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Cell-Free DNA (cfDNA) Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Cell-Free DNA (cfDNA) Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Cell-Free DNA (cfDNA) Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Cell-Free DNA (cfDNA) Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Cell-Free DNA (cfDNA) Testing Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Cell-Free DNA (cfDNA) Testing Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Cell-Free DNA (cfDNA) Testing Market Size Comparison by Region (M USD)
Table 5. Global Cell-Free DNA (cfDNA) Testing Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Cell-Free DNA (cfDNA) Testing Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Cell-Free DNA (cfDNA) Testing Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2022)
Table 10. Global Market Cell-Free DNA (cfDNA) Testing Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Cell-Free DNA (cfDNA) Testing Sales Sites and Area Served
Table 12. Manufacturers Cell-Free DNA (cfDNA) Testing Product Type
Table 13. Global Cell-Free DNA (cfDNA) Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Cell-Free DNA (cfDNA) Testing
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Cell-Free DNA (cfDNA) Testing Market Challenges
Table 22. Global Cell-Free DNA (cfDNA) Testing Sales by Type (K Units)
Table 23. Global Cell-Free DNA (cfDNA) Testing Market Size by Type (M USD)
Table 24. Global Cell-Free DNA (cfDNA) Testing Sales (K Units) by Type (2019-2024)
Table 25. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Type (2019-2024)
Table 26. Global Cell-Free DNA (cfDNA) Testing Market Size (M USD) by Type (2019-2024)
Table 27. Global Cell-Free DNA (cfDNA) Testing Market Size Share by Type (2019-2024)
Table 28. Global Cell-Free DNA (cfDNA) Testing Price (USD/Unit) by Type (2019-2024)
Table 29. Global Cell-Free DNA (cfDNA) Testing Sales (K Units) by Application
Table 30. Global Cell-Free DNA (cfDNA) Testing Market Size by Application
Table 31. Global Cell-Free DNA (cfDNA) Testing Sales by Application (2019-2024) & (K Units)
Table 32. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Application (2019-2024)
Table 33. Global Cell-Free DNA (cfDNA) Testing Sales by Application (2019-2024) & (M USD)
Table 34. Global Cell-Free DNA (cfDNA) Testing Market Share by Application (2019-2024)
Table 35. Global Cell-Free DNA (cfDNA) Testing Sales Growth Rate by Application (2019-2024)
Table 36. Global Cell-Free DNA (cfDNA) Testing Sales by Region (2019-2024) & (K Units)
Table 37. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Region (2019-2024)
Table 38. North America Cell-Free DNA (cfDNA) Testing Sales by Country (2019-2024) & (K Units)
Table 39. Europe Cell-Free DNA (cfDNA) Testing Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Cell-Free DNA (cfDNA) Testing Sales by Region (2019-2024) & (K Units)
Table 41. South America Cell-Free DNA (cfDNA) Testing Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Cell-Free DNA (cfDNA) Testing Sales by Region (2019-2024) & (K Units)
Table 43. Agilent Technology Cell-Free DNA (cfDNA) Testing Basic Information
Table 44. Agilent Technology Cell-Free DNA (cfDNA) Testing Product Overview
Table 45. Agilent Technology Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Agilent Technology Business Overview
Table 47. Agilent Technology Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 48. Agilent Technology Recent Developments
Table 49. Allenex Cell-Free DNA (cfDNA) Testing Basic Information
Table 50. Allenex Cell-Free DNA (cfDNA) Testing Product Overview
Table 51. Allenex Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Allenex Business Overview
Table 53. Allenex Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 54. Allenex Recent Developments
Table 55. Biocept Cell-Free DNA (cfDNA) Testing Basic Information
Table 56. Biocept Cell-Free DNA (cfDNA) Testing Product Overview
Table 57. Biocept Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Biocept Cell-Free DNA (cfDNA) Testing SWOT Analysis
Table 59. Biocept Business Overview
Table 60. Biocept Recent Developments
Table 61. Biodesix Cell-Free DNA (cfDNA) Testing Basic Information
Table 62. Biodesix Cell-Free DNA (cfDNA) Testing Product Overview
Table 63. Biodesix Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Biodesix Business Overview
Table 65. Biodesix Recent Developments
Table 66. CareDx Cell-Free DNA (cfDNA) Testing Basic Information
Table 67. CareDx Cell-Free DNA (cfDNA) Testing Product Overview
Table 68. CareDx Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. CareDx Business Overview
Table 70. CareDx Recent Developments
Table 71. Guardant Health Cell-Free DNA (cfDNA) Testing Basic Information
Table 72. Guardant Health Cell-Free DNA (cfDNA) Testing Product Overview
Table 73. Guardant Health Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Guardant Health Business Overview
Table 75. Guardant Health Recent Developments
Table 76. Illumania Cell-Free DNA (cfDNA) Testing Basic Information
Table 77. Illumania Cell-Free DNA (cfDNA) Testing Product Overview
Table 78. Illumania Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Illumania Business Overview
Table 80. Illumania Recent Developments
Table 81. Invited Cell-Free DNA (cfDNA) Testing Basic Information
Table 82. Invited Cell-Free DNA (cfDNA) Testing Product Overview
Table 83. Invited Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Invited Business Overview
Table 85. Invited Recent Developments
Table 86. Natera Cell-Free DNA (cfDNA) Testing Basic Information
Table 87. Natera Cell-Free DNA (cfDNA) Testing Product Overview
Table 88. Natera Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Natera Business Overview
Table 90. Natera Recent Developments
Table 91. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Basic Information
Table 92. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product Overview
Table 93. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Quest Diagnostics Business Overview
Table 95. Quest Diagnostics Recent Developments
Table 96. Roche Holdings Cell-Free DNA (cfDNA) Testing Basic Information
Table 97. Roche Holdings Cell-Free DNA (cfDNA) Testing Product Overview
Table 98. Roche Holdings Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Roche Holdings Business Overview
Table 100. Roche Holdings Recent Developments
Table 101. Sequenom Cell-Free DNA (cfDNA) Testing Basic Information
Table 102. Sequenom Cell-Free DNA (cfDNA) Testing Product Overview
Table 103. Sequenom Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Sequenom Business Overview
Table 105. Sequenom Recent Developments
Table 106. Trovagene Cell-Free DNA (cfDNA) Testing Basic Information
Table 107. Trovagene Cell-Free DNA (cfDNA) Testing Product Overview
Table 108. Trovagene Cell-Free DNA (cfDNA) Testing Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Trovagene Business Overview
Table 110. Trovagene Recent Developments
Table 111. Global Cell-Free DNA (cfDNA) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Cell-Free DNA (cfDNA) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Cell-Free DNA (cfDNA) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Cell-Free DNA (cfDNA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Cell-Free DNA (cfDNA) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Cell-Free DNA (cfDNA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Cell-Free DNA (cfDNA) Testing Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Cell-Free DNA (cfDNA) Testing Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Cell-Free DNA (cfDNA) Testing Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Cell-Free DNA (cfDNA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Cell-Free DNA (cfDNA) Testing Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Cell-Free DNA (cfDNA) Testing Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Cell-Free DNA (cfDNA) Testing Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Cell-Free DNA (cfDNA) Testing Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Cell-Free DNA (cfDNA) Testing Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Cell-Free DNA (cfDNA) Testing Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Cell-Free DNA (cfDNA) Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell-Free DNA (cfDNA) Testing Market Size (M USD), 2019-2030
Figure 5. Global Cell-Free DNA (cfDNA) Testing Market Size (M USD) (2019-2030)
Figure 6. Global Cell-Free DNA (cfDNA) Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell-Free DNA (cfDNA) Testing Market Size by Country (M USD)
Figure 11. Cell-Free DNA (cfDNA) Testing Sales Share by Manufacturers in 2023
Figure 12. Global Cell-Free DNA (cfDNA) Testing Revenue Share by Manufacturers in 2023
Figure 13. Cell-Free DNA (cfDNA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cell-Free DNA (cfDNA) Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cell-Free DNA (cfDNA) Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cell-Free DNA (cfDNA) Testing Market Share by Type
Figure 18. Sales Market Share of Cell-Free DNA (cfDNA) Testing by Type (2019-2024)
Figure 19. Sales Market Share of Cell-Free DNA (cfDNA) Testing by Type in 2023
Figure 20. Market Size Share of Cell-Free DNA (cfDNA) Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Cell-Free DNA (cfDNA) Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell-Free DNA (cfDNA) Testing Market Share by Application
Figure 24. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Application in 2023
Figure 26. Global Cell-Free DNA (cfDNA) Testing Market Share by Application (2019-2024)
Figure 27. Global Cell-Free DNA (cfDNA) Testing Market Share by Application in 2023
Figure 28. Global Cell-Free DNA (cfDNA) Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cell-Free DNA (cfDNA) Testing Sales Market Share by Country in 2023
Figure 32. U.S. Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cell-Free DNA (cfDNA) Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cell-Free DNA (cfDNA) Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cell-Free DNA (cfDNA) Testing Sales Market Share by Country in 2023
Figure 37. Germany Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cell-Free DNA (cfDNA) Testing Sales Market Share by Region in 2023
Figure 44. China Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (K Units)
Figure 50. South America Cell-Free DNA (cfDNA) Testing Sales Market Share by Country in 2023
Figure 51. Brazil Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cell-Free DNA (cfDNA) Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cell-Free DNA (cfDNA) Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cell-Free DNA (cfDNA) Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cell-Free DNA (cfDNA) Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cell-Free DNA (cfDNA) Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Cell-Free DNA (cfDNA) Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Cell-Free DNA (cfDNA) Testing Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Cell-Free DNA (cfDNA) Testing
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cell-Free DNA (cfDNA) Testing Market Size (M USD), 2019-2030
Figure 5. Global Cell-Free DNA (cfDNA) Testing Market Size (M USD) (2019-2030)
Figure 6. Global Cell-Free DNA (cfDNA) Testing Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Cell-Free DNA (cfDNA) Testing Market Size by Country (M USD)
Figure 11. Cell-Free DNA (cfDNA) Testing Sales Share by Manufacturers in 2023
Figure 12. Global Cell-Free DNA (cfDNA) Testing Revenue Share by Manufacturers in 2023
Figure 13. Cell-Free DNA (cfDNA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Cell-Free DNA (cfDNA) Testing Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Cell-Free DNA (cfDNA) Testing Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Cell-Free DNA (cfDNA) Testing Market Share by Type
Figure 18. Sales Market Share of Cell-Free DNA (cfDNA) Testing by Type (2019-2024)
Figure 19. Sales Market Share of Cell-Free DNA (cfDNA) Testing by Type in 2023
Figure 20. Market Size Share of Cell-Free DNA (cfDNA) Testing by Type (2019-2024)
Figure 21. Market Size Market Share of Cell-Free DNA (cfDNA) Testing by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cell-Free DNA (cfDNA) Testing Market Share by Application
Figure 24. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Application (2019-2024)
Figure 25. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Application in 2023
Figure 26. Global Cell-Free DNA (cfDNA) Testing Market Share by Application (2019-2024)
Figure 27. Global Cell-Free DNA (cfDNA) Testing Market Share by Application in 2023
Figure 28. Global Cell-Free DNA (cfDNA) Testing Sales Growth Rate by Application (2019-2024)
Figure 29. Global Cell-Free DNA (cfDNA) Testing Sales Market Share by Region (2019-2024)
Figure 30. North America Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Cell-Free DNA (cfDNA) Testing Sales Market Share by Country in 2023
Figure 32. U.S. Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Cell-Free DNA (cfDNA) Testing Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Cell-Free DNA (cfDNA) Testing Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Cell-Free DNA (cfDNA) Testing Sales Market Share by Country in 2023
Figure 37. Germany Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Cell-Free DNA (cfDNA) Testing Sales Market Share by Region in 2023
Figure 44. China Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (K Units)
Figure 50. South America Cell-Free DNA (cfDNA) Testing Sales Market Share by Country in 2023
Figure 51. Brazil Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Cell-Free DNA (cfDNA) Testing Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Cell-Free DNA (cfDNA) Testing Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Cell-Free DNA (cfDNA) Testing Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Cell-Free DNA (cfDNA) Testing Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Cell-Free DNA (cfDNA) Testing Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Cell-Free DNA (cfDNA) Testing Market Share Forecast by Type (2025-2030)
Figure 65. Global Cell-Free DNA (cfDNA) Testing Sales Forecast by Application (2025-2030)
Figure 66. Global Cell-Free DNA (cfDNA) Testing Market Share Forecast by Application (2025-2030)
